Related Experiment Video
Updated: May 15, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways
Hirotaka Hoshi1, Tetsuji Sawada, Motoyuki Uchida
1Biomedical Research Laboratories, Kureha Corporation, Shinjuku-ku, Tokyo 169-8503, Japan.
Abstract:
We have previously reported that a specific siRNA transfected MUC5AC could knockdown MUC5AC expression and suppress in vivo tumor growth and metastasis, although it had no effects on in vitro cell growth, cell survival, proliferation and morphology. In the present study, we investigated which host immune cells induced these effects and how the effects were induced using immunocyte-depleted animal models. The tumor growth of SW1990/si-MUC5AC cells, which show no tumor growth when implanted subcutaneously into a nude mouse, was recovered when neutrophils were removed by anti-Gr-1 mAb administration. This result suggests that MUC5AC may suppress the antitumor effects of neutrophils by allowing tumor cells to escape the host immune system. Subsequently, we investigated the effects of MUC5AC on apoptosis induction mediated by TNF-related apoptosis-inducing ligand (TRAIL), one of the antitumor mechanisms of neutrophils. SW1990/si-MUC5AC cells showed significantly increased active caspase 3 expression after the addition of TRAIL. On the other hand, SW1990/si-mock cells showed no such changes. Our results indicate that MUC5AC inhibits TRAIL‑induced apoptosis in human pancreatic cancer and may serve as an important indicator in diagnosis and prognosis.
Insights
Mucin 5AC (MUC5AC) knockdown suppresses pancreatic cancer growth by enabling neutrophil-mediated tumor cell apoptosis. MUC5AC inhibits tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell death.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Previous studies showed MUC5AC siRNA suppressed in vivo tumor growth and metastasis without affecting in vitro cell characteristics.
- The specific host immune cells and mechanisms responsible for MUC5AC's in vivo effects remained unclear.
Purpose of the Study:
- To identify the host immune cells mediating the antitumor effects of MUC5AC knockdown.
- To elucidate the mechanism by which MUC5AC influences tumor cell susceptibility to immune attack, specifically TRAIL-induced apoptosis.
Main Methods:
- Utilized immunocyte-depleted animal models (nude mice) to assess tumor growth after MUC5AC knockdown.
- Administered anti-Gr-1 mAb to deplete neutrophils and observed effects on SW1990/si-MUC5AC tumor growth.
- Investigated the impact of MUC5AC on TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by measuring active caspase 3 expression.
Main Results:
- Depletion of neutrophils using anti-Gr-1 mAb restored tumor growth of SW1990/si-MUC5AC cells, indicating neutrophils mediate the antitumor effect.
- MUC5AC knockdown cells (SW1990/si-MUC5AC) exhibited significantly increased active caspase 3 expression upon TRAIL treatment compared to control cells.
- MUC5AC appears to protect tumor cells from TRAIL-induced apoptosis, suggesting a mechanism for immune evasion.
Conclusions:
- Neutrophils are key host immune cells suppressing MUC5AC-expressing pancreatic tumor growth.
- MUC5AC inhibits neutrophil-mediated antitumor activity by preventing TRAIL-induced apoptosis in pancreatic cancer cells.
- MUC5AC may serve as a diagnostic and prognostic biomarker in human pancreatic cancer.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Acute Pancreatitis II: Pathophysiology

